CHANGES IN MUSCLE STRUCTURE IN DYSTROPHIC PATIENTS, CARRIERS AND NORMAL SIBLINGS SEEN BY ELECTRON MICROSCOPY; CORRELATION WITH LEVELS OF SERUM CREATINEPHOSPHOKINASE (CPK)*-Reference-Cited by-同舟云学术

CHANGES IN MUSCLE STRUCTURE IN DYSTROPHIC PATIENTS, CARRIERS AND NORMAL SIBLINGS SEEN BY ELECTRON MICROSCOPY; CORRELATION WITH LEVELS OF SERUM CREATINEPHOSPHOKINASE (CPK)*

Published:2006-12-16 Issue:1 Volume:138 Page:246-292
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Milhorat A. T.,Shafiq S. A.,Goldstone L.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1966.tb41170.x/fullpdf

Reference45 articles.

1. The carrier state in muscular dystrophy of the Duchenne type: Identification by serum creatine kinase level;Milhorat;J. Am. Med. Assoc,1965

2. High creatine phosphokinase activity in sera of progressive muscular dystrophy;Ebashi;J. Biochem,1959

3. S-collidine as a basis for buffering fixatives;Bennett;J. Biophys. Biochem. Cytol,1959

4. Improvements in epoxy resin embedding methods;Luft;J. Biophys. Biochem. Cytol,1961

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D ₃ ‐creatine dilution for skeletal muscle mass measurement: historical development and current status;Journal of Cachexia, Sarcopenia and Muscle;2022-09-05

2. Creatine Kinase as a Biomarker;Biomarkers in Disease: Methods, Discoveries and Applications;2022

3. Creatine Kinase as a Biomarker;Biomarkers in Disease: Methods, Discoveries and Applications;2022

4. Postnatal Hyperplasic Effects of ActRIIB Blockade in a Severely Dystrophic Muscle;Journal of Cellular Physiology;2017-02-16

5. In vivo treatment with the NF-κB inhibitor ursodeoxycholic acid (UDCA) improves tension development in the isolated mdx costal diaphragm;Muscle & Nerve;2015-12-29